1. Home
  2. PCRX vs PXED Comparison

PCRX vs PXED Comparison

Compare PCRX & PXED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.04

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

PXED

Phoenix Education Partners Inc.

N/A

Current Price

$28.61

Market Cap

1.0B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
PCRX
PXED
Founded
2006
1976
Country
United States
United States
Employees
N/A
3400
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
PCRX
PXED
Price
$23.04
$28.61
Analyst Decision
Strong Buy
Buy
Analyst Count
4
7
Target Price
$30.25
$44.29
AVG Volume (30 Days)
497.5K
76.0K
Earning Date
04-30-2026
04-07-2026
Dividend Yield
N/A
3.07%
EPS Growth
107.44
N/A
EPS
0.07
N/A
Revenue
$541,533,000.00
N/A
Revenue This Year
$6.78
$3.85
Revenue Next Year
$8.54
$4.49
P/E Ratio
$318.71
$11.20
Revenue Growth
26.04
N/A
52 Week Low
$18.80
$23.52
52 Week High
$27.64
$38.19

Technical Indicators

Market Signals
Indicator
PCRX
PXED
Relative Strength Index (RSI) 45.79 45.19
Support Level $21.80 $26.44
Resistance Level $24.20 $30.85
Average True Range (ATR) 1.23 1.41
MACD -0.20 -0.08
Stochastic Oscillator 21.31 8.88

Price Performance

Historical Comparison
PCRX
PXED

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About PXED Phoenix Education Partners Inc.

Phoenix Education Partners Inc. is a mission-driven organization operating at the forefront of the rapidly evolving post-secondary education market. it is an online education provider and a pioneer in its field. The company benefits from the dynamic interplay between technological innovation, education, employment, and economic trends. It is focused on delivering personalized, career-relevant, and affordable education to its students through its flexible learning model, skills-aligned curriculum, and accessible tuition costs.

Share on Social Networks: